SLC5A2 and hydrops fetalis: Concurrently, the CONFIRMATION-HF trial (NCT06024746) is testing a combination strategy of finerenone plus an SGLT2 inhibitor versus usual care in hospitalized patients to determine the safety and efficacy of rapid, simultaneous guideline-directed medical therapy implementation.